Custom Integrated Circuits

Contains reports on nine research projects.Analog Devices, Inc.International Business Machines CorporationJoint Services Electronics Program Contract DAAL03-89-C-0001U.S. Air Force - Office of Scientific Research Contract AFOSR 86-0164BDuPont CorporationNational Science Foundation Grant MIP 88-14612U.S. Navy - Office of Naval Research Contract N00014-87-K-0825American Telephone and TelegraphDigital Equipment CorporationNational Science Foundation Grant MIP 88-5876

Custom Integrated Circuits

Contains reports on twelve research projects.Analog Devices, Inc.International Business Machines, Inc.Joint Services Electronics Program (Contract DAAL03-86-K-0002)Joint Services Electronics Program (Contract DAAL03-89-C-0001)U.S. Air Force - Office of Scientific Research (Grant AFOSR 86-0164)Rockwell International CorporationOKI Semiconductor, Inc.U.S. Navy - Office of Naval Research (Contract N00014-81-K-0742)Charles Stark Draper LaboratoryNational Science Foundation (Grant MIP 84-07285)National Science Foundation (Grant MIP 87-14969)Battelle LaboratoriesNational Science Foundation (Grant MIP 88-14612)DuPont CorporationDefense Advanced Research Projects Agency/U.S. Navy - Office of Naval Research (Contract N00014-87-K-0825)American Telephone and TelegraphDigital Equipment CorporationNational Science Foundation (Grant MIP-88-58764

Custom Integrated Circuits

Contains reports on ten research projects.Analog Devices, Inc.IBM CorporationNational Science Foundation/Defense Advanced Research Projects Agency Grant MIP 88-14612Analog Devices Career Development Assistant ProfessorshipU.S. Navy - Office of Naval Research Contract N0014-87-K-0825AT&TDigital Equipment CorporationNational Science Foundation Grant MIP 88-5876

Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease

BACKGROUND: The cholesteryl ester transfer protein inhibitor evacetrapib substantially raises the high-density lipoprotein (HDL) cholesterol level, reduces the low-density lipoprotein (LDL) cholesterol level, and enhances cellular cholesterol efflux capacity. We sought to determine the effect of evacetrapib on major adverse cardiovascular outcomes in patients with high-risk vascular disease. METHODS: In a multicenter, randomized, double-blind, placebo-controlled phase 3 trial, we enrolled 12,092 patients who had at least one of the following conditions: an acute coronary syndrome within the previous 30 to 365 days, cerebrovascular atherosclerotic disease, peripheral vascular arterial disease, or diabetes mellitus with coronary artery disease. Patients were randomly assigned to receive either evacetrapib at a dose of 130 mg or matching placebo, administered daily, in addition to standard medical therapy. The primary efficacy end point was the first occurrence of any component of the composite of death from cardiovascular causes, myocardial infarction, stroke, coronary revascularization, or hospitalization for unstable angina. RESULTS: At 3 months, a 31.1% decrease in the mean LDL cholesterol level was observed with evacetrapib versus a 6.0% increase with placebo, and a 133.2% increase in the mean HDL cholesterol level was seen with evacetrapib versus a 1.6% increase with placebo. After 1363 of the planned 1670 primary end-point events had occurred, the data and safety monitoring board recommended that the trial be terminated early because of a lack of efficacy. After a median of 26 months of evacetrapib or placebo, a primary end-point event occurred in 12.9% of the patients in the evacetrapib group and in 12.8% of those in the placebo group (hazard ratio, 1.01; 95% confidence interval, 0.91 to 1.11; P=0.91). CONCLUSIONS: Although the cholesteryl ester transfer protein inhibitor evacetrapib had favorable effects on established lipid biomarkers, treatment with evacetrapib did not result in a lower rate of cardiovascular events than placebo among patients with high-risk vascular disease. (Funded by Eli Lilly; ACCELERATE ClinicalTrials.gov number, NCT01687998 .)

Emergence phenology and ecological interactions between the exotic Sirex noctilio, native siricids, and a shared guild of native parasitoids

Sirex noctilio Fabricius is an exotic wasp utilizing host trees within the genus Pinus. Previous invasions in the southern hemisphere have resulted in devastating economic impacts and established populations were detected in the U.S. and adjoining Canada in 2005. Objectives of this study were to describe the ecology and interactions between S. noctilio, native siricids, and their associated parasitoid guild. Natural emergence phenologies were developed for this complex by rearing 30 infested red and Scots pines from two pine stands in 2010 and 60 pines from seven stands in 2011. Degree-day accumulation to emergence was quantified to assist landowners and managers to combat this insect where it becomes a problem. Parasitism was quantified across all sites to generate a more comprehensive understanding of Sirex-parasitoid interactions at the landscape scale. In 2010, two new associations were documented between S. noctilio and a rhyssine parasitoid, Rhyssa crevieri, and the cleptoparasitoid Pseudorhyssa nigricornis . Key Words : Sirex edwardsii, Sirex nigricornis, degree-day, competition, percent parasitism, population density

Comparing functional traits and abundance of invasive versus native woodwasps

Functional traits are useful for comparing the resource use of invasive and native species, with goals of identifying resource overlap to predict competitive interactions. The invasion of northeastern North America by the woodwasp Sirex noctilio has resulted in competition with the native congeneric Sirex nigricornis for suppressed and weakened pines. We compared sizes of adults, venom glands, fecundity, tree species use, voltinism and abundance of the invasive woodwasp S. noctilio with the native S. nigricornis in northeastern North American pines. Rearing adults from attacked pines showed that these species used the same tree species but S. noctilio were far more abundant, especially with increasing time since establishment. Adults of the invasive S. noctilio were larger than S. nigricornis, female S. noctilio had larger glands carrying phytotoxic venom in relation to body size, average-sized S. noctilio females carried more eggs, and S. noctilio developed faster than S. nigricornis. Sirex noctilio was the dominant woodwasp infesting suppressed pines in our study areas. We hypothesize that the future abundance of S. nigricornis could depend in part on the availability of wood for oviposition by this native that is not available or acceptable to the earlier-emerging S. noctilio

Comparing functional traits and abundance of invasive versus native woodwasps

Functional traits are useful for comparing the resource use of invasive and native species, with goals of identifying resource overlap to predict competitive interactions. The invasion of northeastern North America by the woodwasp Sirex noctilio has resulted in competition with the native congeneric Sirex nigricornis for suppressed and weakened pines. We compared sizes of adults, venom glands, fecundity, tree species use, voltinism and abundance of the invasive woodwasp S. noctilio with the native S. nigricornis in northeastern North American pines. Rearing adults from attacked pines showed that these species used the same tree species but S. noctilio were far more abundant, especially with increasing time since establishment. Adults of the invasive S. noctilio were larger than S. nigricornis, female S. noctilio had larger glands carrying phytotoxic venom in relation to body size, average-sized S. noctilio females carried more eggs, and S. noctilio developed faster than S. nigricornis. Sirex noctilio was the dominant woodwasp infesting suppressed pines in our study areas. We hypothesize that the future abundance of S. nigricornis could depend in part on the availability of wood for oviposition by this native that is not available or acceptable to the earlier-emerging S. noctilio